News

BIDIPHAR RANKS AMONG FORBES VIETNAM’S TOP 50 BEST LISTED COMPANIES IN 2024

18/07/2024

Binh Dinh Pharmaceutical and Medical Equipment Joint Stock Company (Bidiphar) has been officially recognized by Forbes Vietnam in the prestigious “Top 50 Best Listed Companies” list for 2024. This marks the first time Bidiphar has achieved this esteemed position, underscoring the company’s credibility and strength in the Vietnamese stock market.

The “Top 50 Best Listed Companies” list, published annually by Forbes Vietnam, is one of the most reputable rankings, reflecting the significant changes and dynamics of the Vietnamese economy. This year, amidst a volatile stock market and challenges in international fundraising, Bidiphar’s inclusion in the list stands as a clear testament to the company’s relentless efforts and outstanding achievements.

BIDIPHAR VÀO TOP 50 CÔNG TY NIÊM YẾT TỐT NHẤT NĂM 2024" DO TẠP CHÍ FORBES BÌNH CHỌN

BIDIPHAR RANKS AMONG FORBES VIETNAM’S TOP 50 BEST LISTED COMPANIES IN 2024

Ms. Pham Thi Thanh Huong, General Director of Bidiphar, shared, “We are immensely proud to be recognized by Forbes Vietnam among the Top 50 Best Listed Companies. This accolade not only acknowledges the continuous efforts of all Bidiphar employees but also motivates us to further advance in the future.”

With 44 years of experience in the pharmaceutical and medical equipment sectors, Bidiphar has persistently strived to research, develop, and apply advanced technologies in production to provide high-quality products that meet the ever-increasing demands of consumers. The company prioritizes product quality, adhering to international quality management standards to ensure product safety and efficacy.

In the past year, Bidiphar has achieved significant milestones, contributing notably to the growth of the Vietnamese pharmaceutical industry. The company’s revenue in 2023 reached VND 1,731 billion, with after-tax profits amounting to VND 269.1 billion, reflecting a 10% increase compared to the previous year. These figures not only demonstrate strong growth but also indicate stable and sustainable business performance.

BIDIPHAR VÀO TOP 50 CÔNG TY NIÊM YẾT TỐT NHẤT NĂM 2024" DO TẠP CHÍ FORBES BÌNH CHỌN

BIDIPHAR RANKS AMONG FORBES VIETNAM’S TOP 50 BEST LISTED COMPANIES IN 2024

Additionally, Bidiphar places great emphasis on developing high-quality human resources, considering this a key factor for sustainable development. The company regularly organizes training programs to enhance the knowledge and skills of its staff, fostering an environment where they can maximize their potential and creativity.

Being honored in Forbes Vietnam’s “Top 50 Best Listed Companies” list is a significant milestone for Bidiphar, reaffirming its position in the pharmaceutical and medical equipment industry. This recognition also presents an opportunity for Bidiphar to expand its market presence, both domestically and internationally, thereby enhancing the standing of the Vietnamese pharmaceutical industry on the global stage.

With a 2030 vision to become one of the top three pharmaceutical companies in Vietnam, Bidiphar is committed to robust investments in research and development, technological innovation, and improving product and service quality to best meet the needs of customers and the community. The company also aims for sustainable development, aligned with social responsibility and environmental protection, contributing to a healthier and more sustainable society.

Facebook

View More